Results

Total Results: 2,207 records

Showing results for "drug".

81. Femur Neck | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/health-topics/femur-neck
    April 23, 2019 - Femur Neck Products Systematic Review Archived April 23, 2019 Long-Term Drug … Therapy and Drug Holidays for Osteoporosis Fracture Prevention: A Systematic Review Research … Protocol April 12, 2018 Long-Term Drug Therapy and Drug Holidays for Osteoporotic Fracture Prevention

82. Comparative Effectiveness of Drug Therapy for Rheumatoid Arthritis in Adults – An Update to the 2007 Report | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/rheumatoid-arthritis-medicine/research-protocol
    December 01, 2019 - Home Evidence Reports Comparative Effectiveness of Drug … Food and Drug Administration (FDA) for the treatment RA at the time of the first review. … The Key Questions (KQs) Question 1: For patients with RA, do drug therapies differ in their ability … Question 3: For patients with RA, do drug therapies differ in harms, tolerability, patient adherence … Food and Drug Administration (FDA).

83. Pharmacotherapy for Adults With Alcohol-Use Disorders in Outpatient Settings | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/alcohol-misuse-drug-therapy/research-protocol
    January 01, 2021 - Economic cost of alcohol and drug abuse in the United States, 1992: a report. … Hazardous drinkers and drug users in HMO primary care: prevalence, medical conditions, and costs. … Drug Alcohol Depend. 2006 Feb 1;81(2):149-55. PMID: 16043307. Hasin DS, Grant BF. … Drug and Alcohol Abuse: A Clinical Guide to Diagnosis and Treatment. 6th ed. … https://effectivehealthcare.ahrq.gov/products/alcohol-misuse-drug-therapy/research-protocol

84. Comparative Effectiveness of Drug Therapy for Psoriatic Arthritis in Adults – An Update to the 2007 Report | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/arthritis-psoriatric/research-protocol
    December 01, 2019 - Home Evidence Reports Comparative Effectiveness of Drug … SHARE: Comparative Effectiveness of Drug … Food and Drug Administration (FDA) to treat patients with PsA are adalimumab, etanercept, golimumab, … The first review did not include certolizumab pegol, golimumab, and tocilizumab drug therapies listed … KQ3: For patients with psoriatic arthritis, do drug therapies differ in harms, tolerability, adherence

85. Pharmacological treatment | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/health-topics/pharmacological-treatment
    September 26, 2023 - Chronic Pain: Systematic Review Systematic Review Archived April 23, 2019 Long-Term Drug … Therapy and Drug Holidays for Osteoporosis Fracture Prevention: A Systematic Review Research … Treatment of Acute Pain: An Evidence Map Research Protocol April 12, 2018 Long-Term Drug … Therapy and Drug Holidays for Osteoporotic Fracture Prevention Consumer Summary Archived

86. S131 (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/s131.pdf
    October 01, 2007 - Prevalent users of a drug have by definition persisted in their drug use, similar to the concept of survivor … to the drug). … likely to use the same drug again. … subjects who did not use any drug of this class. … of a drug in a given patient.

87. Making Healthcare Safer IV | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/collections/making-healthcare-safer-IV
    January 01, 2025 - and Outcome Measurements To Improve the Safety of Surgical Care Opioid Stewardship Reducing Adverse Drug … Harms in Older Adults Computerized Clinical Decision Support To Prevent Medication Errors and Adverse Drug … Making Healthcare Safer IV: Active Infection Surveillance of Clostridioides difficile and Multi-Drug … | Sep 7, 2023 Making Healthcare Safer IV: Prevention of Transmission of Infection With Multi-Drug … | Feb 9, 2024 Computerized Clinical Decision Support To Prevent Medication Errors and Adverse Drug

88. AHRQ's Evidence-based Practice Center Division Annual Report 2019: Solving the Puzzle for Evidence-Based Decision Making (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-year-in-review-2019.pdf
    January 01, 2019 - Delirium Comparative Effectiveness of Analgesics To Reduce Acute Pain in the Prehospital Setting Long-Term Drug … Therapy and Drug Holidays for Osteoporosis Fracture Prevention: A Systematic Review Management of Infertility … Study Comparative Effectiveness of Analgesics to Reduce Acute Pain in the Prehospital Setting Long-Term Drug … Therapy and Drug Discontinuations and Holidays for Osteoporosis Fracture Prevention: A Systematic Review … www.tandfonline.com/doi/full/10.1080/10903127.2019.1657213 https://annals.org/aim/fullarticle/2731605/long-term-drug-therapy-drug-discontinuations-holidays-osteoporosis-fracture-prevention

89. Migraine-Adults-Executive-130408 (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/migraine-adults-executive-130408.pdf
    April 01, 2013 - , patient education, drug surveillance, or interactive drug monitoring) influence results? … , patient education, drug surveillance, or interactive drug monitoring) influence results? … care, patient education, drug surveillance, or interactive drug monitoring) influence results? … care, patient education, drug surveillance, or interactive drug monitoring) influence results? … Food and Drug Administration.

90. PULMONARY with "Discussions" in Exec Summary (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/13_pulmonary_potential_high_impact_june_2012.pdf
    January 01, 2012 - The drug has been granted orphan drug designation. … Available: http://www.vrtx.com/current-projects/drug- candidates/vx-770.html. 3. … Food and Drug Administration (FDA); 2012 Jan 31 [accessed 2012 Feb 22]. [2 p]. … /current-projects/drug-candidates/vx-770.html http://investors.vrtx.com/releasedetail.cfm? … Oral treprostinil new drug application accepted by FDA for review. [internet].

91. PULMONARY with "Discussions" in Exec Summary (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/13_pulmonary_potential_high_impact_2012-12-11.pdf
    January 01, 2012 - Ivacaftor in combination with another experimental CF drug, VX-809, has also been shown to improve … Even for patients with prescription drug coverage, copayments are expected to be significant. … Available: http://www.vrtx.com/current- projects/drug-candidates/vx-770.html. 3. … Food and Drug Administration (FDA); 2012 Jan 31 [accessed 2012 Feb 22]. [2 p]. … /current-projects/drug-candidates/vx-770.html http://investors.vrtx.com/releasedetail.cfm?

92. S29 (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/s29.pdf
    October 01, 2007 - 1 study drug was a newer drug (“on the market for 1 yr”)? … Compare drug to nondrug alternative (vs. drug-drug comparison) Possibly acceptable if the treatments … Newer drug (1 drug on the market for only a year vs. both drugs on the market for “quite a while”) More … “You are making one drug your preferred drug; does that also mean you are going to take the other drug … and make it your nonpreferred drug?

93. Off-Label Use of Atypical Antipsychotics: An Update | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/atypical-antipsychotics-off-label-update/research
    March 01, 2020 - Food and Drug Administration (FDA) for treatment of schizophrenia, bipolar disorder, and for some drugs … ziprasidone, asenapine, iloperidone, paliperidone) to either placebo, another atypical antipsychotic drug … White Paper Jan 07, 2025 Enhancing Systematic Review Methods by Incorporating Unpublished Drug

94. Data Points #9: Utilization of antidiabetic drugs among Medicare beneficiaries with diabetes, 2006-2009 | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/diabetes-drugs-utilization/research
    December 01, 2019 - Overview Biguanides (i.e., metformin) were the most commonly used antidiabetic drug class among Medicare … patterns for rosiglitazone changed dramatically when the 2007 meta-analysis was published and the Food and Drug … The goals of this report are to: (1) present general antidiabetic drug utilization patterns among the … Medicare Part D; and (2) focus on the utilization of the four most frequently dispensed antidiabetic drug

95. Effective Health Care (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0404_01-14-2011.pdf
    January 01, 2011 - are the long-term (> 90-day) mortality, morbidity, and functional outcomes associated with various drug … Compare two newer drug therapies, both FDA approved, for the treatment of PAH (inhaled treprostinil … Compare combination drug therapies to monotherapy drug treatment Pulmonary Arterial Hypertension … Based on disease etiology and severity of the disease, the timing and optimal combinations of drug therapy … In order to optimize PAH care, newer information regarding the latest drug therapies and combination

96. S81 (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/s81.pdf
    October 01, 2007 - for drug-induced delirium/ psychosis. … In contrast, few ICD-9-CM codes specifically describe drug exposure. … A wide variety of commonly used drug classes cause delir- ium. … Aggregate variables of ICD-9-CM codes that indicated drug- TABLE 1. … Drug Saf. 1999;20:109–117. 14. Hurdle JF, Weir CR, Roth B, et al.

97. Making Healthcare Safer IV: Active Infection Surveillance of Clostridioides difficile and Multi-Drug Resistant Organisms: Methicillin-Resistant Staphylococcus aureus (MRSA), Carbapenem-Resistant Enterobacterales (CRE), Candida auris | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/mhs4-active-infection/protocol
    September 01, 2023 - Making Healthcare Safer IV: Active Infection Surveillance of Clostridioides difficile and Multi-Drug … Making Healthcare Safer IV: Active Infection Surveillance of Clostridioides difficile and Multi-Drug … details. 1 Preventing exposure, colonization, and infection of Clostridioides difficile and multi-drug … | Sep 7, 2023 Making Healthcare Safer IV: Prevention of Transmission of Infection With Multi-Drug … | Feb 9, 2024 Computerized Clinical Decision Support To Prevent Medication Errors and Adverse Drug

98. Evidence Report on the (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/dietary-supplements_research-protocol.pdf
    December 15, 2010 - and Drug-Dietary Supplement Interactions: In the clinical setting, drug-supplement interactions are … more difficult to interpret than drug-drug interactions for a variety of reasons. … Due to U.S. drug regulatory policy, much more research and data are available describing drug-drug interactions … b. . . .cause alterations in cellular drug-transport mechanisms (e.g., drug-transport proteins)? … of the mechanisms of absorption and distribution of an administered drug, the rate at which a drug

99. Comparative Effectiveness of Preventive Pharmacological Treatments for Migraine | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/migraine-prevention/research-protocol
    December 01, 2019 - Food and Drug Administration (FDA) for migraine prevention in adults come from different drug classes … surveillance, or interactive drug monitoring. … , patient education, drug surveillance, or interactive drug monitoring) influence results? … , patient education, drug surveillance, or interactive drug monitoring) influence results? … Pharmacological classes for migraine prevention Drug, ATC Code* Class of Drug ANTIEPILEPTICS

100. Disposition of Comments for Migraine in Adults: Preventive Pharmacologic Treatments (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/migraine-prevention_disposition-comments.pdf
     April 18, 2013 - We used the WHO drug classification system that does not include tonabersat. … We corrected the drug class for this medication following your recommendations. 3. … We added the tables with the numbers of the enrolled for each drug class. … We found no trials that reported drug effects in gender subgroups. … We requested the FDA review of this drug.